Serum levels of SIL-6R and GP130 in PMR patients: Prognostic value of SIL-6R levels in patients with relapses

被引：0
|
作者：
Pulsatelli, L. [1 ]
Boiardi, L. [2 ]
Consonni, D. [3 ]
Dolzani, P. [4 ]
Silvestri, T. [4 ]
Macchioni, P. [2 ]
Cantini, F. [5 ]
Facchini, A.
Salvarani, C. [2 ]
Meliconi, R. [4 ]
机构：
[1] Ist Ortoped Rizzoli, Lab Immunol & Genet, Bologna, Italy
[2] Arcispedale S Maria nuova, Serv Reumatol, Reggio Emilia, Italy
[3] Azienda Osped, Ist Clin Perfezionamento, Milan, Italy
[4] Univ Bologna, Ist Ortoped Rizzoli, Bologna, Italy
[5] Osped Prato, Prato, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [31] The balance of interleukin (IL)-6, IL-6•soluble IL-6 receptor (sIL-6R), and IL-6•sIL-6R•sgp130 complexes allows simultaneous classic and trans-signaling
    Baran, Paul
    Hansen, Selina
    Waetzig, Georg H.
    Akbarzadeh, Mohammad
    Lamertz, Larissa
    Huber, Heinrich J.
    Ahmadian, M. Reza
    Moll, Jens M.
    Scheller, Juergen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (18) : 6762 - 6775
  • [32] The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor
    DeJongh, R
    Vranken, J
    Vundelinckx, G
    Bosmans, E
    Maes, M
    Heylen, R
    CYTOKINE, 1997, 9 (09) : 696 - 701
  • [33] The IL-6/sIL-6R complex as a novel target for therapeutic approaches
    Rose-John, Stefan
    Waetzig, Georg H.
    Scheller, Juergen
    Groetzinger, Joachim
    Seegert, Dirk
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (05) : 613 - 624
  • [34] Levels of interleukin-6 (IL-6) and its soluble (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives
    Öktem, S
    Yavuzsen, TU
    Sengül, B
    Akhunlar, H
    Akar, S
    Tunca, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : S34 - S36
  • [35] Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients
    Sadeghi, Mahmoud
    Daniel, Volker
    Naujokat, Cord
    Mehrabi, Arianeb
    Opelz, Gerhard
    TRANSPLANTATION, 2006, 81 (12) : 1716 - 1724
  • [36] The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; The soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth
    MurakamiMori, K
    Taga, T
    Kishimoto, T
    Nakamura, S
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (04) : 595 - 602
  • [37] Autologous Vaccine, Active Immunotherapy of Cancer Patients According to TNF-α, IFN-γ, sIL-2R, sIL-6R Monitoring
    Anthopoulos, Hannes
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 915 - 915
  • [38] 肺癌患者血清sIL-6R检测的临床研究
    王静
    张茂林
    马利军
    孙培宗
    王俊平
    董君
    张罗献
    河南医科大学学报, 2000, (03) : 255 - 257
  • [39] sIL-6R effected on the growth of MM cells via induction of activation of JAK/STATS and increment of sIL-6R reduced the apoptosis of U266 cells by anticancer drugs
    Ahn, K. S.
    Bae, E. K.
    Park, J. W.
    Kim, B. S.
    Bang, S. M.
    Kim, I. H.
    Yoon, S. S.
    Lee, D. S.
    Park, S.
    Kim, B. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 121 - 121
  • [40] Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-α-induced depressive symptoms in patients with malignant melanoma
    Friebe, Astrid
    Schwarz, Markus J.
    Schmid-Wendtner, Monika
    Volkenandt, Matthias
    Schmidt, Folkhart
    Horn, Martin
    Janssen, Gesa
    Schaefer, Martin
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (03) : 333 - 337
12345